We are monitoring the impact of COVID-19 on Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 896
Share on
Share on

Global Hormone Replacement Therapy Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Type, Route of Administration & Region - Industry Forecast (2021 to 2026)

Pulished: February, 2020
ID: 896
Pages: 185

Global Hormone Replacement Therapy Market Size (2021 to 2026):

The global hormone replacement therapy market size was worth USD 16.89 billion in 2021 and to grow USD 23.92 billion by 2026, showcasing a CAGR of 7.21% during the forecast period.

Hormonal replacement therapy is a medical term used to substitute the natural hormones present in the human body with other hormones. Hormone replacement therapy (HRT) is the latest technological roadmap that targets the hormonal imbalance in people. This process involves the stimulation or induction of hormones like estrogen, thyroid-stimulating hormone (TSH), testosterone, etc.

MARKET DRIVERS:

The rising geriatric population and behavioral changes are majorly driving the global hormone replacement therapy market growth.

As People age is increasing, their health concerns increase, resulting in chronic illness in the population. So as to reduce the impact of diseases, hormonal balance is necessary. In the case of lactating women, hormones like progesterone and estrogen play a vital role due to the behavioral changes in women’s lifestyle; there is a huge demand for hormone therapy in pre and post-pregnancy and lactating periods, respectively. Apart from these aspects, increased expenditure on R&D and people's consciousness for health are also the aspects that are driving the global hormone replacement therapy market for further expansion.

There are many opportunities for the HRT process; due to the people's behavioral aspects, there is a lot of scope for global hormone replacement therapy market expansion. Many Non-curable diseases are now days addressed with Hormone therapy techniques. Particularly in the case of women experiencing menopause in the very early stage, like in the mid-40s are stating their interest in exploring the HR therapies for estrogen and progesterone therapies. Impotent males and people who have the medical illness are tilting towards these kinds of safe hormone replacement therapies. The market is currently valued at around USD 17,800 million and is expected to reach USD 29.685 million by 2027, with an annual CAGR of 7.2% over the forecast period. Increased investments in developing countries for such advanced therapies provide a big opportunity for the market players to expand and capture the segment in those countries.

MARKET RESTRAINTS:

The high cost of these therapies, some side effects, and product shortages due to weak pipelines are some of the factors that are supposed to hinder the global hormone replacement therapy market growth.

Generally, harmonic imbalances are quite natural in people who do not maintain a proper lifestyle, so correcting those imbalances is a tedious task and requires a lot of effort both behaviorally and financially. So, it is a barrier for the market. Regulatory approvals for these kinds of therapies are much complex and cannot be obtained easily. As these kinds of therapies are highly advanced, less developed countries lack awareness and cannot afford to invest in these kinds of research. Less penetration and lack of prominent players in major markets like APAC are barriers to the global hormone replacement therapy market expansion.

In Hormone replacement therapies process is involved where there is a disease that is involved with hormonal imbalance. As the adjoining cells should not be disturbed, the therapy involves targeting particular cells. So, this makes Hormone replacement therapy costlier. Also, HRTs make the patients more exposed to risks from cancer and cell disorders. Apart from all the above-stated factors getting regulatory approvals for the HRTs either for clinical research or application is quite challenging in nature.

COVID-19 Impact on the global hormone replacement therapy market:

The COVID-19 pandemic has disrupted the market initially due to the supply chain and demand-side disruptions. But the players in the market had opened up the market to new avenues. There is ongoing research to apply the HRTs in treating the covid 19 infected patients. There are some findings that the recovery and survival rates in post-menopausal women are high. So, scientists are relating the effect of estrogen in inhibiting the virulence caused by the covid 19. There are also ongoing clinical trials to infuse estradiol to increase the immunity in the women patients to reduce the infection caused by covid 19. Not only estradiol but also many other hormone replacement therapies are being researched clinically to cure the covid 19 infected patients.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Basis of Route of Administration and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global hormone replacement therapy market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2026.

Hormone Replacement Therapy Market - By Type:

  • Estrogenic Replacement Therapy
  • Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy

Based on type, with a market share of more than 60%, the estrogenic replacement therapy segment dominates the market. Estrogenic Replacement Therapy is accounted for more than 50% of the share market. This replacement therapy in which estrogenic hormones are commonly used to treat the symptoms seen in women for menopause. This helps to decrease short-term changes of menopause like vaginal dryness, hot flashes, and disturbed sleep in women.

Hormone Replacement Therapy Market - By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Other Routes

Based on the route of administration, the oral route of the administration segment is regarded to be one of the safest and most preferred routes of drug administration. The Oral Route of Administration segment is accounted for the highest share market.  This oral segment is a sub-division of enteral administration.

Hormone Replacement Therapy Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Geographically, the North American region is likely to dominate the global market during the forecast period due to the factors such as new methods or products in drug delivery systems, developing new drugs, and increase in target people population. Also, the growing incidence of menopause disorders, the rising prevalence of hormone deficiency disorders, and the awareness among the people related to these therapies further drive the North American regional market.

The Asia-Pacific market is likely to register the highest growth rate over the forecast period due to the factors such as awareness among people regarding hormone replacement therapy in APAC countries such as China, India, and Japan.

The Middle East and Africa are likely to have moderate demand due to increasing occurrences of chronic diseases like cancer that require hormone replacement therapy.

KEY MARKET PARTICIPANTS:

Some of the prominent companies operating in the global hormone replacement therapy market profiled in the report are Abbott Laboratories, Novartis, Pfizer, Mylan Laboratories, Amgen, Merck & Co, Bayer, Eli Lily, Novo Nordisk, Wyeth, F. Hoffmann-La Roche, and Hisamitsu Pharmaceutical Co. Inc.

Leading companies are focusing on collaborations and mergers, which are anticipated over the next seven years to share the cost of technology and innovation in this area. 

RECENT MARKET DEVELOPMENTS:

  • On December 17, 2019, Pfizer, Inc. introduced a new drug known as Xtandi, which has received acceptance from U.S. FDA.  This Xtandi is a combination of anti-hormone therapy and helps in the reduction of cancer spreading.
  • On May 09, 2007, Wyeth’s new drug Pristiq suffering from the symptoms of menopause like hot flashes without an important impact. The U.S. FDA has approved this for the treatment and this one of the hormone replacement therapy.
  • Pfizer completed the Weiss merger in December 2014, outpacing popular products such as Prempro and Premarin.

1.Introduction       

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                                

2. Research Methodology                

                2.1 Introduction   

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview           

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                   

                 5.1 By Hormone Type                                   

                                5.1.1 Estrogen Replacement Therapy                     

                                5.1.2 Growth Hormone Replacement Therapy                   

                                5.1.3 Thyroid Replacement Therapy                       

                                5.1.4 Others                      

                5.2 By Route of Administration                                 

                                5.2.1 Oral                            

                                5.2.2 Parenteral               

                                5.2.3 Transdermal                           

                                5.2.4 Others                      

6. Geographical Analysis                   

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                                6.3.6 Australia                  

                6.4 Latin America 

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                6.5 Middle East & Africa                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                        

7. Pipeline Product Analysis            

                7.1 Overview         

                7.2 Pipeline Development Landscape         

                7.3 Molecular Targets in the Pipeline          

                7.4 Clinical Trials  

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8.Strategic Analysis             

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis   

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9.Market Leaders' Analysis               

                9.1 Abbott Laboratories                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Financial analysis                  

                                9.1.4 Recent Developments                       

                                9.1.5 SWOT analysis                       

                                9.1.6 Analyst View                          

                9.2 Novartis                                       

                9.3 Pfizer 

                9.4 Mylan Laboratories                                 

                9.5 Amgen                                         

                9.6 Merck & Co.                               

                9.7 Bayer 

                9.8 Eli Lily & Company                                  

                9.9 Novo Nordisk 

                9.10 Wyeth                                        

                9.11 F. Hoffmann-La Roche                                         

                9.12 Hisamitsu Pharmaceutical  Co. Inc.                                 

10.Competitive Landscape               

                10.1 Market share analysis                                          

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11.Expert Opinions              

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                

                a) List of Tables                                

                b) List of Figures   

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  2. Global Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  3. Global Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  4. Global Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  5. Global Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  6. Global Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  7. Global Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  8. North America Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  9. North America Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  10. North America Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  11. North America Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  12. North America Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  13. North America Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  14. North America Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  15. United States Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  16. United States Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  17. Canada Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  18. Canada Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  19. Europe Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  20. Europe Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  21. Europe Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  22. Europe Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  23. Europe Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  24. Europe Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  25. Europe Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  26. United Kingdom Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  27. United Kingdom Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  28. Spain Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  29. Spain Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  30. Germany Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  31. Germany Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  32. France Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  33. France Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  34. Italy Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  35. Italy Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  36. Asia-Pacific Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  37. Asia-Pacific Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  38. Asia-Pacific Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  39. Asia-Pacific Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  40. Asia-Pacific Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  41. Asia-Pacific Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  42. India Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  43. India Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  44. China Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  45. China Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  46. Japan Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  47. Japan Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  48. South Korea Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  49. South Korea Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  50. Australia Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  51. Australia Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  52. Latin America Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  53. Latin America Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  54. Latin America Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  55. Latin America Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  56. Latin America Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  57. Latin America Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  58. Argentina Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  59. Argentina Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  60. Brazil Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  61. Brazil Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  62. Mexico Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  63. Mexico Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  64. Middle East & Africa Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  65. Middle East & Africa Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  66. Middle East & Africa Estrogen Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  67. Middle East & Africa Growth Hormone Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  68. Middle East & Africa Thyroid Replacement Therapy Market By Region, From 2021 to 2026 (USD Billion)
  69. Middle East & Africa Other Hormone Therapies Market By Region, From 2021 to 2026 (USD Billion)
  70. Middle East Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  71. Middle East Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)
  72. Africa Hormone Replacement Therapy Market By Hormone Type, From 2021 to 2026 (USD Billion)
  73. Africa Hormone Replacement Therapy Market By Route of Administration, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample